ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Merus NV

Merus NV (2GH)

42.20
0.80
(1.93%)
Closed December 07 4:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
42.20
Bid
41.80
Ask
42.80
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

2GH Latest News

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M
A6NAsana Inc
21.00 €
(43.84%)
19.08k
NL8Genesis Ai Corp
0.0214 €
(40.79%)
13.33k
RQ0DWave Quantum Inc
4.814 €
(34.92%)
1.15M
K8DWellfield Technologies Inc
0.0342 €
(34.65%)
30.8k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
M0YNMynaric AG
1.40 €
(-72.66%)
303.13k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.0028 €
(-98.58%)
1.59B
D7GNel ASA
0.2625 €
(-1.69%)
4.24M
LK1Lake Resources
0.029 €
(-6.75%)
2.32M
TUI1Tui AG
8.40 €
(1.11%)
2.17M
TE9Teco 2030 ASA
0.0592 €
(65.36%)
2.11M

Discussion

View Full Feed
StayHumble StayHumble 4 minutes ago
✅21M+ XPERT BUYS $HIRU💹💹💹https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades
HIRU
TrendTrade2016 TrendTrade2016 4 minutes ago
THE AO IS SHOWING LOTS OF GREEN BARS
GVSI
TrendTrade2016 TrendTrade2016 6 minutes ago
STANDARD DEVIATION IS POINTED NORTHBOUND
GVSI
StayHumble StayHumble 6 minutes ago
$AMC💹Silver investment's Golden💹FilmPopularity💹XplodingShortly
AMC
dmb2 dmb2 6 minutes ago
I have requested in the past for you not to respond to my posts as I have no time for uninformed and baseless commentary such as yours.
NWBO
ElementalCorsair27 ElementalCorsair27 8 minutes ago
Condor Gold PLC: Notice of Convening Hearing for Scheme of Arrangement

Condor Gold PLC (AIM: CNR, TSX: COG, OTC: CNDGF) has announced it has issued a Part 8 Claim Form to the Companies Court, seeking an Order to convene a shareholder meeting on 6 January 2025. This meeting will enable
CNR
highlandernew highlandernew 9 minutes ago
🔴🔴Roaring Kitty says TIME for AMC now?: Click...

*** Click on images to zoom? (if needed?) ***

https://investorshub.advfn.com/uimage/uploads/2024/12/6/ldxwdAMC_KITTY.png

https://investorshub.advfn.com/uimage/uploads/2024/12/5/uiljdAMC_5X
AMC
TrendTrade2016 TrendTrade2016 9 minutes ago
TWO NICE INDICATORS...THE TRUE STRENGHT INDEX AND THE KLINGER OSCILATOR BOTH CROSSED
GVSI
trader53 trader53 10 minutes ago
DPLS - Setting Time To Target

*** January 2025 ***

'Green Range' is 'Confirmed'

"No Doubt in my Military Mind" !!

"All Targets" - "Will Get Hit" !!


https://investorshub.advfn.com/uicon/155361.png?cb=6363603107072
DPLS MFI
StayHumble StayHumble 10 minutes ago
Wow✅Silver is the New Gold 💹💹 Cheerful 💹 💹 💹
HYMC
BurgerKing82 BurgerKing82 11 minutes ago
I gotta think this can see .02 relatively quickly
UATG
MartinLutherKing MartinLutherKing 12 minutes ago
News will hit international media
https://www.labiotech.eu/best-biotech/mirna-companies/#transcodetherapeutics
RNAZ
SeaBlue SeaBlue 12 minutes ago
Here is the article....if you view it and then go back later and to try to view it you might not be able to without signing up.

More posturing. I guess this will continue for a while.

First Mining Gold’s Springpole project reaches regulatory milestone
Staff
FFMGF
TrendTrade2016 TrendTrade2016 12 minutes ago
THE MAGIC 4 HOUR FLIP IGNITED THE MOVE
GVSI
StayHumble StayHumble 12 minutes ago
💹Wow 50-$85 Possible!💹 UCLA💹Xerox|Mercedes| AbbeyRoadInst |Santander|Chatsworth|Ernst&Young|Omnisport|PinsentMasons


Facts and Data Speak for Themselves.
Source: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166123457
DBMM
TrendTrade2016 TrendTrade2016 13 minutes ago
AS FOR TRIGGERS UP A HEAD....004 TRIGGER PUSH .0047 TO START!
GVSI
ElementalCorsair27 ElementalCorsair27 16 minutes ago
cryptonews #bitcoin #cryptocurrency #crypto #bitcoins

🌐 Join Stefania Barbaglio in this fascinating episode of Financial Fox as she interviews Adam Back, CEO of Blockstream and an OG and a pioneering figure in the Bitcoin space. Adam shares his visionary insights into Bitc
trader53 trader53 16 minutes ago
DPLS - 'All Targets Will Get Hit'


'Green Range' is 'Confirmed'

"No Doubt in my Military Mind" !!

"All Targets" - "Will Get Hit" !!


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000

https
DPLS MFI
Pennydream Pennydream 16 minutes ago
xrp 🤔 goodluck
its funny ipeak here and same people saying samethings as they were 6 years ago 🤔
ZRFY
TrendTrade2016 TrendTrade2016 17 minutes ago
NOW OF COARSE THE WEEKLY IS NOT IN TREND, BUT LIKE THE PAST COUPLE RUNS...ROOM TO THE SPAN A WHICH SITTING JUST ABOOVE THAT SAR
GVSI
trader53 trader53 18 minutes ago
DPLS - 'Green Range' is 'Confirmed'


"No Doubt in my Military Mind" !!

"All Targets" - "Will Get Hit" !!


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000

https://investorshub.advfn.com/uimage/uploads/2
DPLS MFI
StayHumble StayHumble 19 minutes ago
💹w0w! 💹" No r/s+ MERGER AQUISITION"💹huzzah!💹💹
https://x.com/CorporateUbqu/status/1765510100628726105?s=20
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
UBQU
Pennydream Pennydream 21 minutes ago
cant believe you guys arestill here 😂😂
ZRFY
shajandr shajandr 22 minutes ago
Yep, todos cool. Just one office supply aficionado/connoisseur/addict/junkie tweaking a fellow one. Just good funn, kamerad.

FWIW, I (and DaSun) are mechanical pencil devotees from long back. I have zero (and I mean absolute zero - minus 273.15 degrees Centigrade) artistic talent; DaS
TrendTrade2016 TrendTrade2016 25 minutes ago
INTERMS OF ACUMMULATION INDICATORS....MY TWO FAVORITE ARE SAYING BUYING IS ORGANIC!
GVSI

Your Recent History

Delayed Upgrade Clock